Literature DB >> 21527471

Role of fimV in type II secretion system-dependent protein secretion of Pseudomonas aeruginosa on solid medium.

Gérard P F Michel1, Anthony Aguzzi, Geneviève Ball, Chantal Soscia, Sophie Bleves, Romé Voulhoux.   

Abstract

Although classical type II secretion systems (T2SSs) are widely present in Gram-negative bacteria, atypical T2SSs can be found in some species. In Pseudomonas aeruginosa, in addition to the classical T2SS Xcp, it was reported that two genes, xphA and xqhA, located outside the xcp locus were organized in an operon (PaQa) which encodes the orphan PaQa subunit. This subunit is able to associate with other components of the classical Xcp machinery to form a functional hybrid T2SS. In the present study, using a transcriptional lacZ fusion, we found that the PaQa operon was more efficiently expressed (i) on solid LB agar than in liquid LB medium, (ii) at 25 °C than at 37 °C and (iii) at an early stage of growth. These results suggested an adaptation of the hybrid system to particular environmental conditions. Transposon mutagenesis led to the finding that vfr and fimV genes are required for optimal expression of the orphan PaQa operon in the defined growth conditions used. Using an original culturing device designed to monitor secretion on solid medium, the ring-plate system, we found that T2SS-dependent secretion of exoproteins, namely the elastase LasB, was affected in a fimV deletion mutant. Our findings led to the discovery of an interplay between FimV and the global regulator Vfr triggering the modulation of the level of Vfr and consequently the modulation of T2SS-dependent secretion on solid medium.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21527471     DOI: 10.1099/mic.0.045849-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  7 in total

1.  SutA is a bacterial transcription factor expressed during slow growth in Pseudomonas aeruginosa.

Authors:  Brett M Babin; Megan Bergkessel; Michael J Sweredoski; Annie Moradian; Sonja Hess; Dianne K Newman; David A Tirrell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

2.  Type IV pili mechanochemically regulate virulence factors in Pseudomonas aeruginosa.

Authors:  Alexandre Persat; Yuki F Inclan; Joanne N Engel; Howard A Stone; Zemer Gitai
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-03       Impact factor: 11.205

Review 3.  Bacterial secretins: Mechanisms of assembly and membrane targeting.

Authors:  Yuri Rafael de Oliveira Silva; Carlos Contreras-Martel; Pauline Macheboeuf; Andréa Dessen
Journal:  Protein Sci       Date:  2020-02-19       Impact factor: 6.725

4.  The Conserved Tetratricopeptide Repeat-Containing C-Terminal Domain of Pseudomonas aeruginosa FimV Is Required for Its Cyclic AMP-Dependent and -Independent Functions.

Authors:  Ryan N C Buensuceso; Ylan Nguyen; Kun Zhang; Martin Daniel-Ivad; Seiji N Sugiman-Marangos; Aaron D Fleetwood; Igor B Zhulin; Murray S Junop; P Lynne Howell; Lori L Burrows
Journal:  J Bacteriol       Date:  2016-07-28       Impact factor: 3.490

5.  Modulation of Type III Secretion System in Pseudomonas aeruginosa: Involvement of the PA4857 Gene Product.

Authors:  Miao Zhu; Jingru Zhao; Huaping Kang; Weina Kong; Haihua Liang
Journal:  Front Microbiol       Date:  2016-01-28       Impact factor: 5.640

6.  Pseudomonas aeruginosa Elastase Contributes to the Establishment of Chronic Lung Colonization and Modulates the Immune Response in a Murine Model.

Authors:  Cristina Cigana; Jérôme Castandet; Nicolas Sprynski; Medede Melessike; Lilha Beyria; Serena Ranucci; Beatriz Alcalá-Franco; Alice Rossi; Alessandra Bragonzi; Magdalena Zalacain; Martin Everett
Journal:  Front Microbiol       Date:  2021-01-12       Impact factor: 5.640

7.  Evolution of Acinetobacter baumannii in Clinical Bacteremia Patients.

Authors:  Henan Li; Jiangang Zhang; Zhiren Wang; Yuyao Yin; Hua Gao; Ruobing Wang; Longyang Jin; Qi Wang; Chunjiang Zhao; Zhanwei Wang; Hui Wang
Journal:  Infect Drug Resist       Date:  2021-08-31       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.